Detecting the Tumor — How Noninvasive Diagnostic Testing Is Shaping the Future of Neuro-oncology

Neurosurgeon Chetan Bettegowda discusses the potential for liquid biopsy to offer valuable guidance for physicians treating patients with brain cancer. This noninvasive approach to assessing a patient’s current cancer progression is close to clinical integration and could impact clinical decision making in the future.

Created by

Johns Hopkins Medicine

Related Presenters

Chetan Bettegowda, MD, PhD

Chetan Bettegowda, MD, PhD

Professor of Neurological Surgery

Director, Meningioma Center Professor of Neurosurgery   Languages: English, Kannada  Expertise: Brain Tumors, CyberKnife and stereotactic radiosurgery, Gliomas, Meningiomas, Metastatic Brain Tumors, Neurosurgery, Pituitary Tumors, Skull ...

View full profile